BTIG analysts upheld their Buy rating and $15.00 price target for Coya Therapeutics (NASDAQ:COYA), following recent clinical trial data. The stock, currently trading at $7.11, has shown strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback